Stevens-johnson Syndrome
📧 Sign up to get email alerts when something new happens for Stevens-johnson Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-16Clinical Trial Update: Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
The clinical trial NCT03585946 investigating outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis has been withdrawn, with no…
-
CLINICAL_TRIALS withdrawal · 2017-04-07Clinical Trial Update: Topical Infliximab in Autoimmune Eyes With Keratoprosthesis [Phase 1, Phase 2]
A Phase 1/2 clinical trial of topical infliximab for autoimmune eye conditions with keratoprosthesis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-04Clinical Trial Update: Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) [Phase 1, Phase 2]
The clinical trial evaluating infliximab to improve retention of the Boston Keratoprosthesis in patients after Stevens-Johnson Syndrome/Toxi…